Quantitative Proteomics Analysis of the Hepatitis C Virus Replicon High-Permissive and Low-Permissive Cell Lines

PLoS One. 2015 Nov 6;10(11):e0142082. doi: 10.1371/journal.pone.0142082. eCollection 2015.

Abstract

Chronic hepatitis C virus (HCV) infection is one of the leading causes of severe hepatitis. The molecular mechanisms underlying HCV replication and pathogenesis remain unclear. The development of the subgenome replicon model system significantly enhanced study of HCV. However, the permissiveness of the HCV subgenome replicon greatly differs among different hepatoma cell lines. Proteomic analysis of different permissive cell lines might provide new clues in understanding HCV replication. In this study, to detect potential candidates that might account for the differences in HCV replication. Label-free and iTRAQ labeling were used to analyze the differentially expressed protein profiles between Huh7.5.1 wt and HepG2 cells. A total of 4919 proteins were quantified in which 114 proteins were commonly identified as differentially expressed by both quantitative methods. A total of 37 differential proteins were validated by qRT-PCR. The differential expression of Glutathione S-transferase P (GSTP1), Ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCHL1), carboxylesterase 1 (CES1), vimentin, Proteasome activator complex subunit1 (PSME1), and Cathepsin B (CTSB) were verified by western blot. And over-expression of CTSB or knock-down of vimentin induced significant changes to HCV RNA levels. Additionally, we demonstrated that CTSB was able to inhibit HCV replication and viral protein translation. These results highlight the potential role of CTSB and vimentin in virus replication.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / metabolism*
  • Blotting, Western
  • Carcinoma, Hepatocellular / metabolism*
  • Carcinoma, Hepatocellular / pathology
  • Carcinoma, Hepatocellular / virology
  • Chromatography, Liquid
  • Hepacivirus / genetics
  • Hepacivirus / metabolism*
  • Hepatitis C, Chronic / metabolism*
  • Hepatitis C, Chronic / virology
  • Humans
  • Liver Neoplasms / metabolism
  • Liver Neoplasms / virology
  • Proteome / analysis*
  • Proteomics / methods*
  • RNA, Messenger / genetics
  • Real-Time Polymerase Chain Reaction
  • Replicon / genetics*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tandem Mass Spectrometry
  • Tumor Cells, Cultured
  • Virus Replication

Substances

  • Biomarkers
  • Proteome
  • RNA, Messenger

Grants and funding

This study was supported by National Basic Research Program of China (973 Program) Grant No. 2011CB504902 and Major infectious diseases project, Grant No. 20132X10004601-002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.